Skip to main content
PRPL $6.82 +3.33%
PRPL logo

PRPL · Purple Innovation, Inc.

Track PRPL — free
$6.82 +0.22 (+3.33%) At close · Aug 14
Market Cap
$28.42M
Shares
4.36M
All earnings calls

Earnings call · FY2025 Q4

Purple Innovation, Inc. Q4 FY2025 Earnings Call

Purple Innovation, Inc. Q4 FY2025 Earnings Call

Concluded Mar 31, 2026 Audio replay
Mar 31, 2026 42:46 40 turns
Period
FY2025 Q4
Runtime
42:46
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Purple Innovation reported Q4 2025 revenue up approximately 9% year-over-year with adjusted EBITDA of ~$8.8 million and full-year positive adjusted EBITDA within initial guidance, marking an inflection in profitability driven by wholesale growth and cost initiatives, in a market described as down low single digits.

Wholesale / Mattress Firm expansion 36 Brand and consumer positioning 27 Guidance and capital outlook 27 Showroom / Rejuvenate 2.0 24 Profitability turnaround 18 E-commerce / Amazon 16

Management tone

Confident

Net tone +62 · low hedging

Grounding quotes
  • “Revenue increased approximately 9% year-over-year. We delivered gross profit expansion and profitability improved meaningfully across the business.”
  • “it marks a clear shift from defense to offense. Growth, margin expansion and profitability are showing up in the numbers”
  • “we can continue to grow that as a percent to total, but the physical expansion is completed, and we're now looking to a very full innovation pipeline for other products starting in early '27.”
  • “we're off to a good start for the year for sure.”

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $140.69M +9.1% YoY
Gross margin · derived Q4 38.5% -4.4 pp YoY
Net income · derived Q4 -$3.21M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Q4 revenue increased approximately 9% year-over-year
  • Generated adjusted EBITDA of approximately $8.8 million in Q4 and delivered positive adjusted EBITDA for the full year within initial guidance
  • Wholesale grew 39.8% in Q4, driven by Mattress Firm distribution expansion and a significant Costco program expansion
  • Showroom comparable sales increased 8.8% in Q4 with more than 80% of showrooms four-wall profitable for the full year
  • Rejuvenate 2.0 represented over 50% of showroom mattress revenue, with an average selling price of almost $5,800
  • 2026 guidance of $20 million to $30 million of adjusted EBITDA and expected positive free cash flow for the year

Risks & pressure points

  • E-commerce declined in the fourth quarter, with performance described as mixed during the year
  • Excluding Mattress Firm and the incremental Costco program, retail partner sales were described as net down about 5%
  • Credit agreement maturity extended only to April 30, 2027, with the requirement waived for 2025 financial statements to be delivered without a 'going concern' qualification
  • Paid approximately $1.6 million amendment fee and ~$253,000 in expense reimbursements to lenders in connection with the Third Amendment
  • About 20% of showrooms (roughly nine locations) are not yet four-wall profitable, with three to four potentially needing location/rent restructuring
  • Management stated the broader market remains challenging and is down low single digits

Key moments

Jump directly to management's words in the synchronized transcript.

“For the full year, we expect revenue in the range of $500 million to $520 million and adjusted EBITDA of $20 million to $30 million. This outlook reflects continued momentum in our premium product portfolio, expanded wholesale distribution and the operating leverage in the business as volume grows.” Robert DeMartini, CEO
“The fourth quarter marked an important inflection point for the company. Revenue increased approximately 9% year-over-year. We delivered gross profit expansion and profitability improved meaningfully across the business. In the quarter, we generated adjusted EBITDA of approximately $8.8 million and finished the year profitable.” Robert DeMartini, CEO

Forward guidance

From the 8-K filed Mar 31, 2026.

Metric Guided
Full year revenue
full year 2026
$500M – $520M
Adjusted EBITDA
full year 2026
$20M – $30M
Full-screen source Call document